Vanton Research Laboratory, LLC

vantonlab.com

Vanton Resesarch Laboratory. LLC is a rapid growing pharmaceutical CRO and a specialty pharma company with California HHS granted GMP facility and DEA granted controlled substance license, we specialize in developing novel platform technologies and niche drug delivery systems for various dosage forms – oral controlled release and sustained release tablets, rapid disintegration tablets, transdermal patches, injectable solutions, suspensions, emulsions, microparticles, and liposome formulations.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CPD AND LEARNING

APPLIED BIOMATH, LLC ANNOUNCES PARTNERSHIP WITH ANTENGENE FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | December 09, 2020

news image

Applied BioMath, the business chief in applying frameworks pharmacology and unthinking demonstrating, reproduction, and examination to de-hazard drug innovative work, today reported a joint effort with Antengene Corporation for the advancement of a frameworks pharmacology displaying in immuno-oncology. Applied BioMath will build up a frameworks pharmacology model for a PDL1/41BB bispecific immunizer, ATG-101, in immuno-oncology signs. The model will be utilized to anticipate clinical beginning a...

Read More

PHARMACY MARKET

KEDALION THERAPEUTICS SECURES SERIES B FUNDING AND ANNOUNCES SIGNING OF OPTION TO ACQUIRE AGREEMENT

Kedalion Therapeutics, | November 16, 2021

news image

Kedalion Therapeutics is pleased to announce the completion of its Series B financing led by Novartis and involving a combination of new and existing investors. The Novartis investment includes an Exclusive Option to Acquire the company and its AcuStream™ technology. This agreement follows a Feasibility Study agreement with the AcuStream™ technology signed earlier this year. The subsequent feasibility study has been completed with successful results. Collaboration between the t...

Read More

PHARMA TECH

CALYX NAMED MEDICAL IMAGING PROVIDER BY CLINSCIENCE

Calyx | June 10, 2022

news image

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved provider of centralized medical imaging services by Clinscience, a full service CRO offering smart, end-to-end clinical trial services to the global pharmaceutical industry. "Calyx's commitment to reliably solving the complex aligns with our focus on designing integrated, smart...

Read More

BUSINESS INSIGHTS

MATRIC TO ESTABLISH FIRST AND ONLY NATIONAL CENTER OF EXCELLENCE FOR PHARMACEUTICAL PROCESS DESIGN

The Mid-Atlantic Technology, | March 03, 2022

news image

The Mid-Atlantic Technology, Research & Innovation Center announced it will establish the Center of Excellence for process design, defining a new standardized process development framework to streamline chemical manufacturing processes from laboratory bench through to commercial production. The initial projects will develop continuous processes for critical materials for the pharmaceutical industry currently substantially produced overseas. These new capabilities will be established as a res...

Read More
news image

CPD AND LEARNING

APPLIED BIOMATH, LLC ANNOUNCES PARTNERSHIP WITH ANTENGENE FOR SYSTEMS PHARMACOLOGY MODELING IN ONCOLOGY

Applied BioMath | December 09, 2020

Applied BioMath, the business chief in applying frameworks pharmacology and unthinking demonstrating, reproduction, and examination to de-hazard drug innovative work, today reported a joint effort with Antengene Corporation for the advancement of a frameworks pharmacology displaying in immuno-oncology. Applied BioMath will build up a frameworks pharmacology model for a PDL1/41BB bispecific immunizer, ATG-101, in immuno-oncology signs. The model will be utilized to anticipate clinical beginning a...

Read More
news image

PHARMACY MARKET

KEDALION THERAPEUTICS SECURES SERIES B FUNDING AND ANNOUNCES SIGNING OF OPTION TO ACQUIRE AGREEMENT

Kedalion Therapeutics, | November 16, 2021

Kedalion Therapeutics is pleased to announce the completion of its Series B financing led by Novartis and involving a combination of new and existing investors. The Novartis investment includes an Exclusive Option to Acquire the company and its AcuStream™ technology. This agreement follows a Feasibility Study agreement with the AcuStream™ technology signed earlier this year. The subsequent feasibility study has been completed with successful results. Collaboration between the t...

Read More
news image

PHARMA TECH

CALYX NAMED MEDICAL IMAGING PROVIDER BY CLINSCIENCE

Calyx | June 10, 2022

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, announced it has been named an approved provider of centralized medical imaging services by Clinscience, a full service CRO offering smart, end-to-end clinical trial services to the global pharmaceutical industry. "Calyx's commitment to reliably solving the complex aligns with our focus on designing integrated, smart...

Read More
news image

BUSINESS INSIGHTS

MATRIC TO ESTABLISH FIRST AND ONLY NATIONAL CENTER OF EXCELLENCE FOR PHARMACEUTICAL PROCESS DESIGN

The Mid-Atlantic Technology, | March 03, 2022

The Mid-Atlantic Technology, Research & Innovation Center announced it will establish the Center of Excellence for process design, defining a new standardized process development framework to streamline chemical manufacturing processes from laboratory bench through to commercial production. The initial projects will develop continuous processes for critical materials for the pharmaceutical industry currently substantially produced overseas. These new capabilities will be established as a res...

Read More